Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis

Recurrent Massive Hydrothorax in a Patient with Decompensated Liver Cirrhosis

Aim: to demonstrate the need for a detailed differential diagnosis and selection of therapy in a patient with decompensated liver cirrhosis of combined etiology (HCV infection and primary sclerosing cholangitis). Key points. The patient came to the clinic with complaints of shortness of breath wit...

Full description

Saved in:

Bibliographic Details
Main Authors:	K. S. Zemlyanukhina, I. N. Tikhonov, M. S. Zharkova, O. Yu. Kiseleva, R. Т. Rzayev, V. T. Ivashkin
Format:	Article
Language:	Russian
Published:	Gastro LLC 2024-10-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	liver cirrhosis portal hypertension pneumonia hydrothorax hepatopleural syndrome
Online Access:	https://www.gastro-j.ru/jour/article/view/927
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Hepatic Hydrothorax: The Conundrum and the Oxymoron
by: Sachin Kumar, et al.
Published: (2017-04-01)

Clinical Recommendations of the Russian Scientific Liver Society and Russian Gastroenterological Association on Diagnosis and Treatment of Liver Fibrosis, Cirrhosis and Their Complications
by: V. T. Ivashkin, et al.
Published: (2022-03-01)

Portal-systemic by-pass and the analysis of survival rate research resultsin patients with liver cirrhosis
by: F. G. Nazyrov, et al.
Published: (2007-09-01)

Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
by: Chuan Liu, et al.
Published: (2025-01-01)

From invasive to intuitive: The emerging role of non-invasive models in hepatic decompensation: Editorial on “Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)”
by: Akhil Deshmukh, et al.
Published: (2025-04-01)

The effect of bacterial overgrowth syndrome and bacterial translocation on the course of liver cirrhosis
by: M. S. Zharkova, et al.
Published: (2012-09-01)

Portal vein thrombosis in patients with liver cirrhosis
by: Savić Željka, et al.
Published: (2024-01-01)

COVID-19 in decompensated cirrhosis
by: O. V. Tashchyan, et al.
Published: (2021-01-01)

Evaluating factors associated with the risk of hydrothorax following standard supracostal percutaneous nephrolithotomy
by: Pankaj N. Maheshwari, et al.
Published: (2022-07-01)

Extirpation of rectum for cancer in patient with decompensated liver cirrhosis and portal hypertension
by: P. V. Tsarkov, et al.
Published: (2011-09-01)

Correlation of Portal Hypertensive Gastropathy with the Size of Esophageal Varices in Patients with Decompensated Chronic Liver Disease:
by: Fatima Fakhir Musharraf, et al.
Published: (2024-07-01)

Formation of the pulmonary hypertension in patients with a liver cirrhosis
by: T. P. Kalachyova, et al.
Published: (2009-08-01)

Prospects of Antiangiogenic Therapy for Portal Hypertension in Liver Cirrhosis
by: D. V. Garbuzenko
Published: (2018-11-01)

Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis
by: Anja Tiede, et al.
Published: (2025-01-01)

Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals
by: Georg Semmler, et al.
Published: (2024-12-01)

Principles of portal hypertension treatment at patients with liver cirrhosis
by: Ye. A. Fedosina, et al.
Published: (2012-09-01)

SURGICAL METHODS OF BLEEDING PREVENTION FROM ESOPHAGEAL VARICES IN TREATMENT FOR PATIENTS WITH LIVER CIRRHOSIS
by: M. F. Zarivchatskiy, et al.
Published: (2017-04-01)

Post COVID Condition and Long‐Term COVID‐19 Impact on Hepatic Decompensation and Survival in Cirrhosis: A Propensity Matched Observational Study
by: Prerna Sharma, et al.
Published: (2025-03-01)

Content of Some Endothelium-Dependent Vasoactive Substances of Blood Plasma, Indicators of Renin-Aldosterone System, Natriuretic Hormone in Patients with Decompensated Liver Cirrhosis and their Dependence on the Severity Grade of Portal Hypertension
by: Ferko M.
Published: (2015-12-01)

Diagnosis and Management of Portal Vein Thrombosis in Liver Cirrhosis
by: Cynthia Kurniawan, et al.
Published: (2025-04-01)

Application of venotonics for correction of sinusoidal dysfunction in patients with cirrhosis
by: A. S. Tugushev P. I. Potapenko, et al.
Published: (2015-06-01)

Changes in the Structural and Functional Albumin Properties in Patients with Decompensated Liver Cirrhosis
by: A. A. Turkina, et al.
Published: (2023-06-01)

Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
by: M.I. Tutchenko, et al.
Published: (2024-06-01)

Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial
by: Valeria Perez-Campuzano, et al.
Published: (2025-04-01)

Development and validation of a predictive model for 90-day mortality risk after discharge in patients with cirrhosis and esophagogastric variceal bleeding
by: Yingxin Zeng, et al.
Published: (2025-08-01)

Characteristics and Endoscopy Findings of Liver Cirrhosis Patients at Waled Hospital, Cirebon, Indonesia (2020-2023)
by: Afifah Humaira Azahra, et al.
Published: (2024-12-01)

TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure? Correspondence to editorial on “Insertion of a transjugular intrahepatic portosystemic shunt leads to sustained reversal of systemic inflammation in patients with decompensated liver cirrhosis”
by: Anja Tiede, et al.
Published: (2025-04-01)

Peritoneal Leak Causing Right Sided Hydrothorax in A Case of Chronic Kidney Disease Undergoing Continuous Ambulatory Peritoneal Dialysis: A Case Report From Nepal
by: Kritika Bhattarai, et al.
Published: (2024-11-01)

Supervivencia del paciente cirrótico con gastropatía portal hipertensiva
by: Marlén Pérez Lorenzo, et al.

Risk and causes of gastroesophageal bleeding in patients with liver cirrhosis
by: Benedeto-Stojanov Daniela, et al.
Published: (2007-01-01)

Characteristics of Syntropie Comorbid Extrahepatic Lesions in Patients with Liver Cirrhosis Depending on the Portal Hypertension Severity Degree
by: Abrahamovych M., et al.
Published: (2016-09-01)

Ratio of the blood flow in liver and splenic arteries in patients with various forms of portal hypertension
by: A. S. Tugushev, et al.
Published: (2015-12-01)

Content of Some Endothotelium-Dependent Vasoactive Substances in the Blood of Patients, Depending on the Liver Cirrhosis Severity and the Organism’s Redox System State
by: Abrahamovych M., et al.
Published: (2019-12-01)

Minimal residual ascites 3 months after TIPS implantation implicates worse clinical outcomes in patients with cirrhosis
by: Jim Benjamin Mauz, et al.
Published: (2025-07-01)

Real-world experience with long-term albumin in patients with cirrhosis and ascites
by: Enrico Pompili, et al.
Published: (2024-12-01)

Laparoscopic splenectomy: posterolateral approach in patients with liver cirrhosis and portal hypertension with platelet count lower than 1 × 10 9 /l
by: Guangjin Tian, et al.
Published: (2018-07-01)

Charcteristics of the Autonomic Nervous System in Patients with Liver Cirrhosis and its Dependence on the Severity of Portal Hypertension due to the Values of the Heart Rate Variability Parameters
by: Abrahamovych M., et al.
Published: (2016-07-01)

Methods of risk prediction and monitoring of treatment response rate of bleedings from esophageal varices in patients with liver cirrhosis
by: D. V. Garbuzenko
Published: (2012-04-01)

Neutrophil to Lymphocyte Ratio as a Predictor of Adverse Outcome in Patients with Decompensated Liver Cirrhosis
by: Valeriy D. Lunkov, et al.
Published: (2019-03-01)

Caracterización clínica de pacientes cirróticos con gastropatía portal hipertensiva
by: Marlén Pérez Lorenzo, et al.